Mammary Cell News

Mammary Cell News is an online resource covering the latest research into breast cancer and mammary cells.

Professor April Khademi awarded $100K from Breast Cancer Canada

August 17, 2026

[TMU] Congratulations to Dr. April Khademi who was awarded $100K in funding from Breast Cancer Canada (BCC) in partnership with AstraZeneca Canada. At Dr. Khademi’s Toronto Metropolitan University (TMU) Image Analysis in Medicine Lab, her team is developing AI-based tools to accurately predict a patient’s risk and likely response to different treatments.

UBC Medicine Researchers Awarded More Than $39 Million in CIHR Funding

August 17, 2026

[The University of British Columbia] UBC Faculty of Medicine researchers have been awarded more than $39 million in federal funding through the Canadian Institutes of Health Research (CIHR) Project Grant: Spring 2026 competition.

NK Cells in Breast Cancer

August 14, 2026

[Trends in Immunology] Recent advances in single-cell and spatial profiling reveal that NK-cell failure in breast cancer does not result from simple immune absence but from multilayered constraints imposed by the tumor ecosystem.

Beyond a Single Disease: Review of Rare Histological Subtypes of Triple-Negative Breast Cancer with Implications for Prognosis and Treatment

August 14, 2026

[NPJ Breast Cancer] The authors summarize the clinicopathologic and molecular features of rare TNBC histologies and discuss emerging therapeutic vulnerabilities.

Inhibition of PINK1/Parkin-Mediated Mitophagy Enhances the Susceptibility of Breast Cancer to Cuproptosis

August 14, 2026

[Oncogene] Researchers reported that inhibiting PINK1/Parkin-mediated mitophagy enhances the sensitivity of breast cancer to cuproptosis, offering a novel combined treatment strategy for breast cancer.

Rb-Driven Transcription Limits Its Tumor-Suppressive Effects in Breast Cancer

August 14, 2026

[Nature] Scientists showed that CDK4/6 inhibition induces redistribution of hypophosphorylated retinoblastoma (Rb) protein to promoters and enhancers. CDK4/6 inhibition enhances ER target gene expression in breast cancer cells, patient-derived xenografts and clinical HR+ breast cancer samples in an Rb-dependent manner.

Crosstalk between SELENOF and the Unfolded Protein Response in Breast Epithelium Dictates Cell Fate

August 14, 2026

[Cell Death Discovery] Researchers demonstrated that SELENOF, an understudied selenoprotein, establishes a feedforward regulatory loop with the inositol-requiring enzyme 1α and X-box binding protein 1arm of the unfolded protein response.

LncRNA PCAT7 Drives Tumorigenesis and Glycolytic Reprogramming in Breast Cancer via the ceRNA-Mediated Mir-204-5p/RUNX2 Axis

August 14, 2026

[Cancer Gene Therapy] Investigators explored glycolytic regulation through competing endogenous RNA networks in breast cancer, with the goal of identifying potential prognostic biomarkers and mechanistic targets.

$1 Million Grant Fuels Research on Precise Cancer Radiation

August 14, 2026

[University of Missouri School of Medicine] Researchers from the University of Missouri School of Medicine recently received a $1 million grant from the National Institutes of Health to study the latest technology in cancer research.

Systemic and Local Chronic Inflammation and Hormone Disposition Promote a Tumor-Permissive Environment for Breast Cancer in Older Women

August 6, 2026

[Nature Aging] Researchers examined how age-associated systemic changes relate to alterations in the local breast tumor microenvironment (TME), with a focus on hormone signaling and inflammation. They identified age-related differences in estrogen disposition and inflammatory profiles that are associated with features of an immunologically altered tumor microenvironment.

BCRF Announces $1.5 Million Grant to Support Team ATLAS, a Global Effort to Learn Why Some People Never Develop Cancer

August 6, 2026

[BCRF ] The Breast Cancer Research Foundation (BCRF) announced a $1.5 million grant over five years to support Team ATLAS, an international research collaboration exploring why some people remain breast cancer-free despite age, inherited risk, environmental exposures, or other known risk factors.

Dynamics, Function, and Regulation of Mammary Stem Cells in Development, and Disease

August 6, 2026

[Experimental & Molecular Medicine] The close parallels between mammary stem cells and tumor-initiating cells, particularly their shared plasticity and self-renewal, highlight stemness as a central node linking developmental programs to malignant transformation.

For over a decade, Mammary Cell News has been keeping the global scientific and medical communities informed about the latest research, reviews, and news in the field of mammary tissues. Our editors gather publications on the topic of mammary cell differentiation and characterization, as well as the progression and treatment of breast cancer. We also keep scientists up-to-date on the latest policy changes, job postings, and events.